Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Recombinant Proteins
  4. R&D Systems™ Recombinant Human IL-18/IL-1F4 Protein

R&D Systems™ Recombinant Human IL-18/IL-1F4 Protein

Catalog No. B0032
Change view
Click to view available options
Quantity:
200 μg
25 μg
2 product options available for selection
Product selection table with 2 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
B0032 200 μg
B0035 25 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 2 options available.
2 options
This item is not returnable. View return policy
Catalog No. B0032 Supplier R&D Systems™ Supplier No. B0032
Add to Cart
Add to Cart
This item is not returnable. View return policy

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

The Recombinant Human IL-18/IL-1F4 Protein is derived from E. coli. The Recombinant Human IL-18/IL-1F4 Protein has been validated for the following applications: Bioactivity.

Specifications

For Use With (Application) Bioactivity
Formulation 200μg in 2mL volume of PBS containing 1% sucrose.
Molecular Weight (g/mol) Predicted MW: 18kDa
Quantity 200 μg
Source E. coli-derived human IL-18/IL-1F4 protein 37-193 aa
Storage Requirements Store the unopened product at -70° C. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Do not use past expiration date.
Conjugate Unconjugated
Recombinant Recombinant
Purity or Quality Grade >90%
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.